Payden & Rygel’s Gilead Sciences Inc Position
Does Payden & Rygel own Gilead Sciences Inc (GILD)? Yes — 91.3K shares worth $13M (+0.98% of its 13F portfolio) as of Q1 2026.
Position Value
$13M
Q1 2026
Shares
91.3K
% of Portfolio
+0.98%
Quarters Held
23
currently held
Position History GILD
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 91.3K | $13M | +0.98% |
| Q4 2025 | 91.3K | $11M | +0.77% |
| Q3 2025 | 91.3K | $10M | +0.84% |
| Q2 2025 | 68.4K | $8M | +0.63% |
| Q1 2025 | 180 | $20,000 | 0.00% |
| Q4 2024 | 180 | $17,000 | 0.00% |
| Q3 2024 | 180 | $15,000 | 0.00% |
| Q4 2023 | 2.7K | $217,000 | +0.02% |
| Q2 2023 | 2.7K | $207,000 | +0.01% |
| Q1 2023 | 11.4K | $946,000 | +0.06% |
| Q4 2022 | 11.4K | $979,000 | +0.05% |
| Q3 2022 | 11.4K | $703,000 | +0.04% |
| Q2 2022 | 11.4K | $705,000 | +0.04% |
| Q1 2022 | 11.4K | $678,000 | +0.03% |
| Q4 2021 | 301.7K | $22M | +1.01% |
| Q4 2020 | 1.4K | $82,000 | 0.00% |
| Q3 2020 | 1.4K | $88,000 | +0.01% |
| Q2 2020 | 20.8K | $2M | +0.10% |
| Q1 2020 | 20.8K | $2M | +0.11% |
| Q4 2019 | 19.6K | $1M | +0.08% |
| Q3 2019 | 22.8K | $1M | +0.10% |
| Q2 2019 | 22.8K | $2M | +0.11% |
| Q1 2019 | 22.8K | $1M | +0.11% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Payden & Rygel’s full portfolio or all institutional holders of GILD.